The expert panel of neurologists addressed the issues encountered by patients with a poor nervous system and the influence of COVID-1919 neurological manifestations.
In a recent online webinar, panellists explained the importance of a healthy brain and central nervous system in minimising the risk of neurological disorders.
As the pandemic rages, there is an urgent need to establish neuropathological connections in COVID-19 through autopsies and pathology studies," Dr Dhamija said, sharing his views. Awareness of the structure of the virus and processes of virus-host interaction will help provide a basis for therapeutic treatments.
"He added, "COVID-19 neurological manifestations are undeniable and reflect an amalgamation of a hyperfunctioning immune system, procoagulant condition, and direct virus-induced apoptosis, a combination that may involve a multi-pronged therapeutic success strategy.
Sharing some estimates, he said, “In India, there was a 44% increase in the burden of mental, neurological, and substance use disorders from 1990 to 2013, far exceeding many other Asian countries.” In India, this burden is expected to increase further by 23 percent by 2025, which should ring the medical community with alarm bells.
Dr Sumit shared his views, “The common primary headache is migraine, stress type headache, trigeminal autonomic cephalalgia.” Headache may be secondary to trauma, withdrawal/drug abuse, infection, vascular disorder, etc.